| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/25/1994 | EP0597997A1 Lanthionine bridged peptides |
| 05/25/1994 | EP0597847A1 Synthetic senescent cell antigen |
| 05/25/1994 | EP0597845A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2 |
| 05/25/1994 | EP0597844A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 05/25/1994 | EP0597831A1 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| 05/25/1994 | EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors |
| 05/25/1994 | EP0358660B1 Synthetic inhibitors of mammalian collagenase |
| 05/25/1994 | EP0249629B1 Methods and materials for alleviation of pain symptoms of malignant neoplasia |
| 05/25/1994 | CN1087015A Preparing of pharmaceutical with activity of resolution of thrombus by use of agent directly inhibiting thrombin |
| 05/25/1994 | CN1024668C Process for preparing 2-(2-isoxazolyl)-2-tetrahydrofuran carboxylic acid derivatives |
| 05/24/1994 | US5314996 Isolated nucleotide sequences encoding an: antigen binding site of monoclonal antibody PD41; and antigen associated with prostate adenocarcinomas |
| 05/24/1994 | US5314995 Antitumor |
| 05/24/1994 | US5314992 Controlling immune and antiinflammatory response |
| 05/24/1994 | US5314991 Recombinant 40 KDa Dermatophagoides farinae allergen |
| 05/24/1994 | US5314874 Crosslinked with a polyhydroxy compound; tissue repair |
| 05/24/1994 | US5314873 Milk-protein hydrolyzates and compositions for use as hair and skin treating agent |
| 05/24/1994 | US5314872 Glucan sulfate, stabilized fibroblast growth factor composition |
| 05/24/1994 | US5314818 Human tissue plasminogen activator variants |
| 05/24/1994 | US5314807 Hypotensive agents |
| 05/24/1994 | US5314695 Tissue factor based prothrombin time reagent |
| 05/24/1994 | US5314692 Enzyme premix for feed and method |
| 05/24/1994 | US5314690 Method and composition for treating IgE-mediated allergies |
| 05/24/1994 | CA1329862C Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors |
| 05/24/1994 | CA1329773C Pharmaceutical compositions useful for the treatment of uremia |
| 05/24/1994 | CA1329764C Pharmaceutical compositions |
| 05/24/1994 | CA1329763C Stabilized fgf composition and production thereof |
| 05/24/1994 | CA1329762C Potentiation of erythropoiesis |
| 05/24/1994 | CA1329761C Design of peptide hormones, chemotactic peptides and drug compounds |
| 05/24/1994 | CA1329760C Plasma and recombinant protein formulations in high ionic strength media |
| 05/19/1994 | DE4241659C1 New thrombin-inhibiting protein - used in treatment of thrombosis, angina and arteriosclerosis |
| 05/19/1994 | DE4238779A1 Lyotropic mesophases for pharmaceutical, dermatological or cosmetic use - contains active ingredients from plants e.g. vitamins or proteins such as superoxidedismutase. |
| 05/19/1994 | DE4238778A1 Vektor zur Expression von therapeutisch relevanten Genen Vector for Expression of therapeutically relevant genes |
| 05/19/1994 | DE4238766A1 New inter-species antibodies reactive with cellular antigens - present in all mammals and birds under conditions of stress, useful for treating, preventing or diagnosing e.g. tumours or virus diseases |
| 05/19/1994 | DE4238416A1 Bestimmung von Peptidmotiven auf MHC-Molekülen Determination of peptide motifs on MHC molecules |
| 05/18/1994 | EP0597827A1 Fibroblast growth factor |
| 05/18/1994 | EP0597503A2 ECK receptor ligands |
| 05/18/1994 | EP0597435A1 Pasteurization of hemoglobin |
| 05/18/1994 | EP0597043A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 05/18/1994 | EP0597033A1 Igf-1 to improve the neural condition. |
| 05/18/1994 | EP0597007A1 W/o microemulsions. |
| 05/18/1994 | EP0596969A1 Igf-ii analogues |
| 05/18/1994 | EP0596962A1 Therapeutic compositions and methods |
| 05/18/1994 | EP0596943A1 Process for purifying pentostatin. |
| 05/18/1994 | EP0596935A1 Antiviral pharmaceutical compositions for vaginal administration. |
| 05/18/1994 | EP0596901A1 CHIMERIC tRNA?LYS -RIBOZYME MOLECULES |
| 05/18/1994 | EP0596881A1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector. |
| 05/18/1994 | EP0548177B1 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases |
| 05/18/1994 | EP0502872B1 Methods and materials for expression of human plasminogen variant |
| 05/18/1994 | EP0463043B1 Method for stabilizing the hybridization of complementary polynucleotide sequences |
| 05/18/1994 | EP0328552B1 Thrombin derived polypeptides, compositions and methods for use |
| 05/18/1994 | EP0316429B1 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation |
| 05/18/1994 | EP0248819B1 Recombinant fibroblast growth factors |
| 05/18/1994 | CN1086825A The present invention is concerned with tri- and tetracyclic compounds |
| 05/18/1994 | CN1086824A Calcium channel blocking polypeptide from agelenopsis aperta |
| 05/18/1994 | CN1086708A Memanting-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 05/17/1994 | US5312911 Improved biological activity in the absence of heparin |
| 05/17/1994 | US5312903 Lysine-glycosylated recombinant interleukin-2 |
| 05/17/1994 | US5312900 23K protein with binding specificity for queuine |
| 05/17/1994 | US5312899 Dermorphin analogs |
| 05/17/1994 | US5312834 Eicosapentenoic acid, a-linolenic acid |
| 05/17/1994 | US5312831 Immunology, anticarcinogenic agents and AIDS treatment |
| 05/17/1994 | US5312817 Treatment of fatigue syndrome |
| 05/17/1994 | US5312812 Pharmaceutical compositions comprising novel oligopeptides exhibiting selective inhibiting effect upon the proliferation of hemopoietic cells |
| 05/17/1994 | US5312811 Peptide derivatives and antidemetia agents |
| 05/17/1994 | US5312810 Adenylate cyclase stimulating factor |
| 05/17/1994 | US5312809 Physiologically active substance derived from malt and process for the production thereof |
| 05/17/1994 | US5312808 Polyoxyethylene glycol conjugates with hemoglobin |
| 05/17/1994 | US5312751 Hybridoma producing a monoclonal antibody specific for an antigen of the stratum corneum of human epidermis |
| 05/17/1994 | US5312738 Vancomycins |
| 05/17/1994 | US5312736 DNA-sequence encoding the analog; expression vector containing the sequence; transformed or transfected microorganism or cell line comprising the vector; culture preparation of analog; drug including analog |
| 05/17/1994 | US5312733 Developmental marker gene of CD4-CD8 thymocytes |
| 05/17/1994 | US5312621 Genetic engineering using DNA |
| 05/17/1994 | CA1329546C Method for reperfusion therapy |
| 05/17/1994 | CA1329545C Immunological complex, its preparation and its use |
| 05/17/1994 | CA1329544C Galenic forms of allergens for sublingual administration |
| 05/17/1994 | CA1329543C Human growth hormone formulation |
| 05/17/1994 | CA1329542C Plasma and recombinant protein formulations in low ionic strength media |
| 05/17/1994 | CA1329541C Pharmaceutical composition for relieving side effects of platinum-containing drugs |
| 05/17/1994 | CA1329540C Use of tnf and lt for the preparation of drugs |
| 05/11/1994 | WO1994010569A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE |
| 05/11/1994 | WO1994010344A1 Diagnostic reagents and their use in the detection of human herpesvirus 7 |
| 05/11/1994 | WO1994010338A1 Nuclear hormone receptor-interacting polypeptides and related molecules and methods |
| 05/11/1994 | WO1994010333A1 Crf binding protein |
| 05/11/1994 | WO1994010331A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | WO1994010330A1 Fibronectin binding protein as well as its preparation |
| 05/11/1994 | WO1994010323A1 Virus with modified binding moiety specific for the target cells |
| 05/11/1994 | WO1994010322A1 Adenovirus-mediated ldl receptor gene transfer and targeting |
| 05/11/1994 | WO1994010318A1 Thrombin activatable plasminogen derivatives |
| 05/11/1994 | WO1994010314A1 Allergenic proteins and peptides from johnson grass pollen |
| 05/11/1994 | WO1994010313A2 Interferon tau compositions and methods of use |
| 05/11/1994 | WO1994010310A1 THE St-B17 SEROTONIN RECEPTOR |
| 05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
| 05/11/1994 | WO1994010308A1 Methods of preparing soluble, oligomeric proteins |
| 05/11/1994 | WO1994010305A1 Transformed endothelial cells |
| 05/11/1994 | WO1994010304A1 Marmoset zona pellucida protein zp3 |
| 05/11/1994 | WO1994010303A1 Multidrug resistance gene |
| 05/11/1994 | WO1994010301A1 TNF-α RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-α RIBOZYMES |
| 05/11/1994 | WO1994010300A1 Interaction trap system for isolating novel proteins |
| 05/11/1994 | WO1994010297A1 Process for producing high-purity human gad-1 and gad-2 proteins |
| 05/11/1994 | WO1994010294A1 Human monoclonal antibodies to human parvovirus and methods of making and using thereof |